Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MEDA Ventures is a healthcare venture capital group founded in 2019 by a team of physicians and scientists based in Arlington, Virginia. The firm specializes in investments in healthcare technologies, focusing on sectors such as medical devices, digital health, and therapeutics. Since its inception, MEDA Ventures has made 27 investments, achieving two notable exits. The firm operates with a unique approach, leveraging the extensive experiences of its partners, who include industry experts, decision-makers, and customers within the healthcare space.
MEDA Ventures aims to provide more than just financial backing; it actively supports its portfolio companies through a robust network of medical professionals and institutions. This network facilitates business development, customer discovery, and partnership opportunities, enhancing the growth potential of the startups it invests in. The firm is located at 3033 Wilson Blvd, Suite 700, Arlington, VA, and has developed a reputation for its innovative clinical trial insurance vehicle, which protects investors' capital against potential failures in clinical trials.
MEDA Ventures invests primarily in healthcare technologies, with a focus on pre-seed to Series B stages, particularly Seed and Series A rounds. The firm emphasizes the importance of clinical trials and risk management in its investment strategy. MEDA has developed a unique product to underwrite coverage of startup companies' clinical trials, providing financial protection against potential failures. This innovative approach allows MEDA to mitigate risks associated with clinical-stage investments.
The firm’s partners include physicians, payors, and scientists, which enhances their ability to identify and support promising startups in the healthcare sector. MEDA Ventures seeks to partner with founders who demonstrate a strong understanding of their market and possess a clear vision for their healthcare solutions. The firm’s geographic focus spans both the United States and international markets, allowing it to tap into a diverse range of healthcare innovations.
MEDA Ventures has a diverse portfolio of 27 companies, focusing on healthcare technologies. Notable portfolio companies include:
These companies exemplify the value of MEDA's expertise and extensive network in advancing healthcare solutions. The firm’s portfolio reflects its commitment to supporting innovative healthcare startups that address critical needs in the medical field.
Elizabeth Cho-Fertikh, PhD - Managing Partner. Elizabeth has a background in healthcare innovation and has led multiple successful investments in the medical technology sector.
Tomas Philipson, PhD - Managing Partner. Tomas brings extensive experience in healthcare economics and has been involved in various high-profile healthcare initiatives.
Carolyn Campbell, JD, PhD - Managing Partner. Carolyn specializes in healthcare law and policy, providing valuable insights into regulatory matters affecting portfolio companies.
Anupam B. Jena, MD, PhD - Venture Partner. Anupam is a physician and economist with expertise in health policy and clinical research.
Steve Brooks, MD, MBA - Venture Partner. Steve has a strong background in clinical practice and healthcare management, enhancing MEDA's operational support for startups.
Eric Sun, MD, PhD - Venture Partner. Eric focuses on digital health innovations and has a track record of successful investments in this area.
Laura Beken, MBA - Venture Partner. Laura brings experience in business development and strategic partnerships within the healthcare sector.
Vrushab Gowda, MD, JD - Venture Fellow. Vrushab supports the team with insights into clinical practices and regulatory affairs.
John Brzezenski, MBA - Partner CFO. John oversees financial operations and strategic planning for the firm.
To pitch MEDA Ventures, founders should visit their website at meda.vc. The firm prefers detailed pitch decks that clearly outline the startup's vision, market opportunity, and clinical validation. While there is no formal application portal, founders are encouraged to provide comprehensive information about their business model and growth strategy. Response times may vary, but MEDA Ventures typically reviews submissions promptly and values warm introductions through their network.
As of June 2024, MEDA Ventures has made 27 investments since its founding in 2019, achieving two notable exits. The firm continues to actively support its portfolio companies, leveraging its extensive network of medical professionals and institutions to enhance their growth potential. Fund 1 has achieved a composite gross IRR of approximately 40% for the vintage year 2023, reflecting the firm's effective investment strategy and the success of its portfolio.
What investment criteria does MEDA Ventures use?
MEDA Ventures primarily invests in healthcare technologies at the pre-seed to Series B stages, with a strong emphasis on Seed and Series A rounds. The firm looks for startups that demonstrate a clear understanding of their market and possess innovative solutions in sectors such as medical devices, digital health, and therapeutics.
How can founders pitch to MEDA Ventures?
Founders can pitch their startups by visiting the MEDA Ventures website at meda.vc. The firm encourages detailed presentations that outline the startup's vision, market potential, and clinical validation.
What makes MEDA Ventures different from other VCs?
MEDA Ventures distinguishes itself through its physician-led investment approach and its unique clinical trial insurance vehicle. This innovative funding solution provides downside protection for investors, which is particularly valuable in the healthcare sector where clinical trials can be unpredictable.
What is MEDA Ventures' geographic scope?
The firm invests in both U.S.-based and international healthcare startups, allowing it to access a wide range of innovative solutions across different markets.
What kind of post-investment support does MEDA Ventures provide?
MEDA Ventures offers extensive post-investment support through its network of medical professionals and institutions. This includes assistance with business development, customer discovery, and partnership facilitation, which are crucial for the growth of healthcare startups.
What is the fund size and check size range for MEDA Ventures?
While specific fund sizes are not disclosed, MEDA Ventures typically invests in the range of $500,000 to $2 million per startup, depending on the stage and needs of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.